LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
---|---|---|---|---|---|---|---|---|---|---|
MCF 10A-H2B-mCherry | Neratinib | 1 | 33.32 | 84.90 | 977 | 2722 | 0.3589 | 0.6296 | MN20160318_Q02 | J12 |
MCF 10A-H2B-mCherry | Neratinib | 1 | 35.03 | 84.90 | 31 | 2991 | 0.0104 | -0.1780 | MN20160318_Q02 | E14 |
MCF 10A-H2B-mCherry | Neratinib | 1 | 35.03 | 84.90 | 772 | 2991 | 0.2581 | 0.5366 | MN20160318_Q02 | E14 |
MCF 10A-H2B-mCherry | Neratinib | 1 | 35.03 | 84.90 | 23 | 2991 | 0.0077 | -0.2244 | MN20160318_Q02 | J12 |
MCF 10A-H2B-mCherry | Neratinib | 1 | 35.03 | 84.90 | 943 | 2991 | 0.3153 | 0.5976 | MN20160318_Q02 | J12 |
MCF 10A-H2B-mCherry | Neratinib | 1 | 36.73 | 84.90 | 35 | 3254 | 0.0108 | -0.1550 | MN20160318_Q02 | E14 |
MCF 10A-H2B-mCherry | Neratinib | 1 | 36.73 | 84.90 | 788 | 3254 | 0.2421 | 0.5274 | MN20160318_Q02 | E14 |
MCF 10A-H2B-mCherry | Neratinib | 1 | 36.73 | 84.90 | 39 | 3254 | 0.0120 | -0.1375 | MN20160318_Q02 | J12 |
MCF 10A-H2B-mCherry | Neratinib | 1 | 36.73 | 84.90 | 986 | 3254 | 0.3030 | 0.5939 | MN20160318_Q02 | J12 |
MCF 10A-H2B-mCherry | Neratinib | 1 | 38.43 | 84.90 | 24 | 3459 | 0.0069 | -0.2104 | MN20160318_Q02 | E14 |
MCF 10A-H2B-mCherry | Neratinib | 1 | 38.43 | 84.90 | 807 | 3459 | 0.2333 | 0.5235 | MN20160318_Q02 | E14 |
MCF 10A-H2B-mCherry | Neratinib | 1 | 38.43 | 84.90 | 61 | 3459 | 0.0176 | -0.0599 | MN20160318_Q02 | J12 |
MCF 10A-H2B-mCherry | Neratinib | 1 | 38.43 | 84.90 | 1011 | 3459 | 0.2922 | 0.5891 | MN20160318_Q02 | J12 |
MCF 10A-H2B-mCherry | Neratinib | 1 | 40.14 | 84.90 | 33 | 3682 | 0.0090 | -0.1595 | MN20160318_Q02 | E14 |
MCF 10A-H2B-mCherry | Neratinib | 1 | 40.14 | 84.90 | 811 | 3682 | 0.2203 | 0.5143 | MN20160318_Q02 | E14 |
MCF 10A-H2B-mCherry | Neratinib | 1 | 40.14 | 84.90 | 68 | 3682 | 0.0185 | -0.0400 | MN20160318_Q02 | J12 |
MCF 10A-H2B-mCherry | Neratinib | 1 | 40.14 | 84.90 | 977 | 3682 | 0.2653 | 0.5671 | MN20160318_Q02 | J12 |
MCF 10A-H2B-mCherry | Neratinib | 1 | 41.84 | 84.90 | 16 | 4003 | 0.0040 | -0.2593 | MN20160318_Q02 | E14 |
MCF 10A-H2B-mCherry | Neratinib | 1 | 41.84 | 84.90 | 817 | 4003 | 0.2041 | 0.5027 | MN20160318_Q02 | E14 |
MCF 10A-H2B-mCherry | Neratinib | 1 | 41.84 | 84.90 | 57 | 4003 | 0.0142 | -0.0692 | MN20160318_Q02 | J12 |
MCF 10A-H2B-mCherry | Neratinib | 1 | 41.84 | 84.90 | 1043 | 4003 | 0.2606 | 0.5702 | MN20160318_Q02 | J12 |
MCF 10A-H2B-mCherry | Neratinib | 1 | 43.55 | 84.90 | 21 | 4287 | 0.0049 | -0.2188 | MN20160318_Q02 | E14 |
MCF 10A-H2B-mCherry | Neratinib | 1 | 43.55 | 84.90 | 861 | 4287 | 0.2008 | 0.5059 | MN20160318_Q02 | E14 |
MCF 10A-H2B-mCherry | Neratinib | 1 | 43.55 | 84.90 | 58 | 4287 | 0.0135 | -0.0651 | MN20160318_Q02 | J12 |
MCF 10A-H2B-mCherry | Neratinib | 1 | 43.55 | 84.90 | 1011 | 4287 | 0.2358 | 0.5493 | MN20160318_Q02 | J12 |